WebJul 28, 2024 · We expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19 vaccine, its sole marketed product, when it r... WebApr 4, 2024 · Investor inquiries. Shareholders seeking information can contact investor relations at (240) 268-2024 or email us at [email protected]. Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with … Stock Quote - Novavax Investor Relations Novavax creates transformational vaccines that help address some of the world’s … Events - Novavax Investor Relations Connect with Novavax. Find the addresses and phone numbers for all of our … Meet innovative vaccine technology from Novavax. Our biotech company prevents … SEC Filings - Novavax Investor Relations
Novavax (NVAX) Reports Q2 Loss, Misses Revenue Estimates
WebAug 3, 2024 · Novavax is reporting earnings from Q2 on August 5. 5 analysts expect losses of $3.632 per share as opposed to losses of $0.300 per share in the same quarter of the previous year. Wall Street... WebAug 6, 2024 · Novavax, Inc. ( NASDAQ: NVAX) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Silvia Taylor – Senior Vice President, Corporate … sims 4 cc eyelids
Impala Platinum Holdings Limited (OTCMKTS:IMPUY) Sees …
WebApr 15, 2024 · NASDAQ:NVAX opened at $9.16 on Friday. Novavax has a twelve month low of $5.61 and a twelve month high of $76.77. The company has a market cap of $789.32 … WebAug 5, 2024 · Novavax will host its quarterly conference call today at 4:30 p.m. ET. The dial-in numbers for the conference call are (866) 652-5200 (Domestic) or (412) 317-6060 (International).... WebNov 8, 2024 · Novavax will host its quarterly conference call today at 4:30 p.m. ET. The dial-in numbers for the conference call are (833) 974-2381 (Domestic) or (412) 317-5774 (International). rbg shelby county dissent